Nigeria Unveils Seven Herbal Medicines in Major Push to Reduce Drug Importation

Nigeria Unveils Seven Herbal Medicines in Major Push to Reduce Drug Importation

Nigeria Unveils 7 Herbal Medicines to Boost Local Drug Production

Nigeria unveils seven herbal medicines developed by NNMDA for health conditions including hepatitis B, ulcer, cancer, hypertension and high cholesterol.

Nigeria has taken a major step towards strengthening local pharmaceutical innovation following the unveiling of seven herbal medicine products developed from indigenous medicinal plants by the Nigeria Natural Medicine Development Agency (NNMDA).

The Federal Government says the initiative could help transform Nigeria’s traditional medicine sector, reduce dependence on imported medicines, create jobs and open new opportunities for the country to develop and export natural health products.

The seven products unveiled by the government target a range of health conditions, including hepatitis B, peptic ulcer disease, certain cancers, high cholesterol and hypertension. The development is part of a broader research programme through which the NNMDA says it has developed more than 22 herbal products from indigenous medicinal plants since 2023.

The unveiling took place during an official visit to the agency’s headquarters in Lagos by the Minister of Innovation, Science and Technology, Dr Kingsley Udeh, who also met pharmaceutical industry leaders to discuss ways of moving the products from research and development into commercial production.

Federal Government Targets Nigeria’s Drug Import Dependence

Nigeria has for years faced challenges associated with dependence on imported pharmaceutical products. The latest initiative reflects a growing government interest in using the country’s extensive biodiversity and traditional medicinal knowledge to strengthen domestic healthcare manufacturing.

Speaking during the visit, Udeh said Nigeria possesses thousands of medicinal plants that could potentially be harnessed to address health challenges affecting the population.

The minister stressed that traditional medicine had played an important role in the healthcare of indigenous communities for centuries, adding that the Federal Government was prepared to address some of the challenges limiting the agency’s research and development activities.

One of the major priorities identified by the minister is the establishment of a Clinical Observational Research Centre for the NNMDA.

According to Udeh, the government intends to explore alternative funding mechanisms to begin work on the centre rather than waiting for allocations from the 2027 budget.

He also acknowledged the importance of adequate funding in allowing researchers to advance promising natural medicines through further research and appropriate clinical evaluation.

Seven Herbal Products Unveiled by NNMDA

The NNMDA Director-General, Professor Martins Emeje, provided details about the herbal medicines unveiled during the event.

According to Emeje, the products have been developed from Nigerian medicinal plants and are being produced in standard dosage forms, including capsules, tablets and syrups.

The agency says standardisation is important because it can help ensure consistent formulations and appropriate dosage information as natural medicine products progress through regulatory and research processes.

The products highlighted during the unveiling include Namdavir, Namdacid, Turmegol, Namdorol, Namgor and Zobo Tea, with some products being positioned for more than one health-related application.

1. Namdavir for Hepatitis B Research

One of the products unveiled is Namdavir, a natural medicine developed from an indigenous medicinal plant for hepatitis B.

Emeje said the product has demonstrated activity against the hepatitis B virus during the agency’s research.

Hepatitis B remains an important public health concern in many parts of the world, including Africa. The development of locally researched products could therefore provide an additional avenue for scientific investigation.

However, consumers should not interpret the unveiling of Namdavir as confirmation that it is an established cure for hepatitis B. Further scientific evaluation, regulatory approval and appropriate clinical evidence are important before any medicine can be widely recommended as a treatment.

2. Namdacid for Peptic Ulcer Disease

The second product, Namdacid, is intended for the management of peptic ulcer disease.

Peptic ulcer disease affects the stomach or upper part of the small intestine and can be associated with significant discomfort and complications when not properly managed.

The NNMDA says Namdacid was developed using Nigerian medicinal plants as part of its wider natural medicine research programme.

3. Turmegol and Cancer Research

Another product highlighted by the agency is Turmegol, which Emeje said was developed for research into the management and prevention of certain cancers, including colorectal, ovarian and prostate cancers.

According to the NNMDA leadership, research conducted on the product has produced evidence suggesting that it may have potential in preventing or slowing the progression of certain cancer cells.

Cancer is a complex group of diseases, and claims regarding prevention or treatment require rigorous scientific investigation. Therefore, the product’s unveiling should be viewed in the context of ongoing research rather than as a replacement for established cancer diagnosis and treatment.

The planned Clinical Observational Research Centre could become particularly important in helping researchers undertake further investigations into promising natural medicine candidates.

Namdorol Targets Cholesterol and Hypertension

The NNMDA also unveiled Namdorol, a natural medicine developed for high cholesterol and associated health management.

Emeje said the product had been investigated for efficacy and could also be useful in the management of hypertension.

High cholesterol and high blood pressure are major cardiovascular risk factors, making research into affordable and locally produced healthcare products potentially significant.

Nevertheless, people living with hypertension or high cholesterol should continue to follow advice from qualified healthcare professionals and should not stop prescribed medication simply because a new herbal product has been announced.

Namgor and Zobo Tea Also Unveiled

The agency also presented Namgor, described by Emeje as an aphrodisiac, alongside Zobo Tea, which he said is intended for hypertension management.

The inclusion of these products demonstrates the broad scope of the NNMDA’s research into indigenous plants and traditional medicine.

The agency believes scientific research, standardisation and modern manufacturing processes can help transform traditional medicinal knowledge into products that can be evaluated and potentially developed for wider use.

NNMDA Wants Nigeria to Develop and Export Medicines

One of the strongest messages from the event was the Federal Government’s desire to change Nigeria’s position from a major importer of medicines to a country capable of producing and exporting pharmaceutical and natural medicine products.

Emeje said the country needed to develop its own medicines while building a value chain capable of supporting local manufacturing and international exports.

The NNMDA director-general also disclosed that one of the products unveiled at the event could potentially generate millions of jobs when fully developed across its value chain.

Such a development could have implications beyond healthcare.

A successful natural medicine industry could create opportunities for farmers cultivating medicinal plants, researchers, laboratory scientists, manufacturers, packaging companies, distributors, marketers and exporters.

It could also encourage investment in agriculture, biotechnology, pharmaceutical manufacturing and scientific research.

Billions of Naira in Economic Opportunities

The Federal Government believes Nigeria’s natural medicine sector could become a major economic opportunity.

Udeh said discussions with pharmaceutical industry leaders showed that Nigeria has the potential to produce and export natural medicines worth billions of dollars.

He also argued that the NNMDA could generate substantial revenue through the development and production of natural medicines while contributing to the healthcare needs of Nigerians.

For the sector to achieve this ambition, however, research must be supported by strong quality control, regulatory oversight, reliable manufacturing systems and credible scientific evidence.

Building consumer confidence will also be crucial.

Why Clinical Research Matters

The proposed Clinical Observational Research Centre could play a significant role in the next phase of the NNMDA’s work.

Traditional medicine has long been used by communities across Nigeria, but moving from traditional use to modern healthcare products requires careful scientific validation.

Researchers need to understand issues such as dosage, safety, effectiveness, possible side effects, interactions with other medicines and the appropriate conditions under which a product may be used.

This is particularly important for products associated with serious diseases such as cancer, hepatitis B and hypertension.

The establishment of a dedicated research centre could therefore help strengthen the evidence base for natural medicines developed by Nigerian researchers.

It could also support collaboration between universities, research institutions, hospitals, pharmaceutical companies and international partners.

India and Nigeria Explore Traditional Medicine Collaboration

The event also attracted international interest, with the Consul General of India in Lagos, Shri Kannan, highlighting opportunities for Nigeria and India to cooperate in traditional medicine.

India and Nigeria both have long histories of traditional healing practices and extensive biodiversity.

Kannan said collaboration could cover areas such as medicinal plant research, scientific validation, standardisation, quality assurance, biodiversity conservation, capacity building and academic exchanges.

Such partnerships could potentially help Nigerian researchers gain access to international expertise while also creating opportunities for entrepreneurs and manufacturers in the natural products sector.

International cooperation could be particularly useful as Nigeria seeks to transform traditional medicine from largely informal practices into a modern, research-driven industry.

Can Herbal Medicine Reduce Nigeria’s Drug Import Bill?

The government’s latest initiative raises an important question: can locally developed herbal medicines help Nigeria reduce dependence on imported drugs?

The answer will depend on several factors.

First, promising products must undergo appropriate scientific and regulatory processes. Second, manufacturers need reliable access to quality raw materials. Third, the country requires modern production facilities capable of maintaining consistent standards.

There is also a need for investment in research, intellectual property protection, clinical studies, regulatory capacity and export certification.

If these conditions are met, locally developed medicines could contribute to a stronger pharmaceutical manufacturing ecosystem.

The potential economic impact could extend from medicinal plant cultivation to manufacturing, logistics and international trade.

The Bigger Picture for Nigeria’s Healthcare Industry

The unveiling of the seven products is more than a showcase of herbal medicines. It reflects a broader attempt to connect traditional knowledge, scientific research, local manufacturing and economic development.

Nigeria has enormous biodiversity and a large population requiring affordable and reliable healthcare products.

Harnessing medicinal plants responsibly could create new opportunities for researchers and businesses while preserving indigenous knowledge.

But the success of the initiative should ultimately be measured by scientific evidence, safety, quality, affordability and patient outcomes—not simply by the number of products developed.

For Nigerians, the most important issue is ensuring that new medicines are properly evaluated and approved before they are marketed for public use.

What the NNMDA Herbal Medicine Initiative Means for Nigerians

The initiative could have several long-term benefits if properly implemented.

First, it could encourage more investment in Nigerian pharmaceutical research.

Second, it could provide new markets for farmers growing medicinal plants.

Third, it could create jobs across agriculture, research, manufacturing and distribution.

Fourth, successful products could help Nigeria participate more strongly in the global natural products market.

Finally, stronger domestic research could help reduce the country’s dependence on imported medicines over time.

These potential benefits, however, depend on sustained government support and strict adherence to scientific and regulatory standards.

The unveiling of seven herbal medicines by the Nigeria Natural Medicine Development Agency marks an important development in Nigeria’s efforts to promote local pharmaceutical innovation.

Products including Namdavir, Namdacid, Turmegol, Namdorol, Namgor and Zobo Tea are part of a wider programme aimed at developing natural medicines from Nigeria’s indigenous medicinal plants.

The Federal Government has expressed its intention to support the sector through improved funding, commercialisation and the proposed Clinical Observational Research Centre.

The involvement of pharmaceutical industry leaders and the prospect of collaboration with India could further strengthen the initiative.

Nigeria’s ambition to move from medicine importation towards local production and eventual export is significant. But achieving that goal will require more than unveiling products. It will require long-term investment in scientific research, clinical evaluation, manufacturing infrastructure, regulation and quality assurance.

If these foundations are established, Nigeria’s rich medicinal plant resources could become an important component of both its healthcare system and its growing innovation economy.

FAQ

What are the seven herbal medicines unveiled by the Nigerian government?

The NNMDA highlighted seven products, including Namdavir, Namdacid, Turmegol, Namdorol, Namgor and Zobo Tea. Some products have been described as having more than one intended health application.

What is Namdavir used for?

According to the NNMDA, Namdavir is a natural medicine developed from an indigenous medicinal plant and researched for activity against hepatitis B.

What is Turmegol?

Turmegol is an NNMDA natural medicine product being researched in connection with cancers including colorectal, ovarian and prostate cancers.

What is Namdacid?

Namdacid is a natural medicine developed for the management of peptic ulcer disease, according to the NNMDA.

Can these herbal medicines replace conventional medicine?

The products should not automatically be considered substitutes for prescribed medical treatment. Their development and unveiling do not by themselves establish that they are proven cures. Consumers should consult qualified healthcare professionals and follow regulatory guidance.

Why is the Clinical Observational Research Centre important?

The proposed centre is expected to strengthen research into natural medicines and support further scientific evaluation of products developed from indigenous medicinal plants.

Can Nigeria export herbal medicines?

Nigeria has the potential to develop an export-oriented natural medicine industry, but products intended for international markets must meet applicable scientific, manufacturing and regulatory requirements in Nigeria and destination countries.

Nigeria’s growing investment in natural medicine research could represent a major opportunity for healthcare, agriculture, manufacturing, employment and exports.

The real test will be whether promising discoveries can successfully move from research laboratories to scientifically validated, safe, affordable and properly regulated products that benefit Nigerians and compete in international markets.

>>>> What do you think about Nigeria’s move to develop and manufacture more medicines locally? Share your opinion in the comments and follow MyInfoJet for more Nigerian health, politics, business and national development updates.

 NNMDA herbal medicines, Nigerian natural medicine, herbal medicine development in Nigeria, local drug production Nigeria, Namdavir, Namdacid, Turmegol, Nigerian pharmaceutical industry

 Nigeria Herbal Medicine, NNMDA, Natural Medicine, Healthcare, Pharmaceutical Industry, Drug Production, Nigeria News, Health Innovation, Medicinal Plants, Local Manufacturing